Drug delivery to the lungs from dry powder inhalers
- 1 April 2003
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pulmonary Medicine
- Vol. 9, S17-S20
- https://doi.org/10.1097/00063198-200304001-00005
Abstract
When asthma is being treated, it is essential that sufficient drug is deposited at the site(s) where it is needed. In recent years, many dry powder inhalers have been developed by the pharmaceutical industry. Drug delivery to the lung from dry powder inhalers is dependent upon the patient's peak inhaled flow rate, and so it is very important to be able to assess the amount and location of drug delivered from different devices. Lung deposition has recently been assessed from a new dry powder inhaler, the Novolizer® (ASTA Medica, now VIATRIS GmbH & Co. KG, subsidiary Sofotec GmbH & Co. KG, Frankfurt, Germany), using gamma scintigraphy. It was shown that the Novolizer® deposited significantly more budesonide in the lungs than a Turbuhaler® used either at similar inspiratory flow rates or with similar inspiratory effort. Equivalent clinical efficacy and safety profiles have also been shown in asthmatic patients treated with budesonide from each device.Keywords
This publication has 16 references indexed in Scilit:
- Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhalerRespiratory Medicine, 2002
- Three-Dimensional Imaging of Aerosol DepositionJournal of Aerosol Medicine, 2001
- Regional Distribution and Kinetics of Inhaled PharmaceuticalsCurrent Pharmaceutical Design, 2000
- Latest advances in the development of dry powder inhalersPharmaceutical Science & Technology Today, 2000
- Scintigraphic comparison of budesonide deposition from two dry powder inhalersEuropean Respiratory Journal, 2000
- Pulmonary Drug Delivery from the Taifun Dry Powder Inhaler Is Relatively Independent of the Patient's Inspiratory EffortJournal of Aerosol Medicine, 2000
- New guidelines on asthma managementBMJ, 1997
- A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler, at two inhaled flow ratesInternational Journal of Pharmaceutics, 1994
- Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjectsEuropean Respiratory Journal, 1994
- Drug delivery to the respiratory tract using dry powder inhalersInternational Journal of Pharmaceutics, 1994